| Age (yr) |
Gender |
Diagnosis |
Mannitol (g) |
Potassium concentration (mEq/L) |
Peak time (min)* |
Authors |
| Before IV |
Peak |
End of surgery |
| 52 |
Male |
SAH |
60 |
4.8 |
6.8 |
5.0 |
40 |
Seto et al.[5] |
| 34 |
Male |
SAH |
60 |
3.1 |
5.4 |
3.5 |
20 |
Hirota et al.[6] |
| 68 |
Male |
ICH |
100 |
4.1 |
6.1 |
5.4 |
60 |
Hirota et al.[6] |
| 15 |
Male |
AVM |
120 |
3.4 |
6.6 |
5.1 |
50 |
Kimura et al.[7] |
| 31 |
Female |
Tumor |
80 |
4.1 |
6.1 |
4.4 |
20 |
Hassan et al.[8] |
| 41 |
Male |
SAH |
120 |
NR |
7.5 |
3.9 |
50¶ |
Flynn [9] |
| 43 |
Male |
Tumor |
60 |
4.8 |
6.7 |
4.0 |
30¶ |
Tobita et al.[10] |
| 57 |
Male |
SAH |
45 |
4.0 |
6 |
4.4 |
110 |
Current report |
| 49 |
Male |
SAH |
30 |
3.7 |
5.7 |
5 |
150 |
Current report |
*Time between completion of mannitol infusion and peak concentration of potassium
¶Time between initiation of mannitol infusion and peak concentration of potassium
NR: not reported, SAH: Subarachnoid hemorrhage, ICH: Intracerebral hemorrhage, AVM: Arteriovenous malformation |
